LifeVantage Announces $5 Million Share Repurchase Program
November 27 2017 - 8:30AM
LifeVantage Corporation (Nasdaq:LFVN) announced today that its
Board of Directors has approved up to $5 million in stock
repurchases. The Company expects to fund the repurchase program
through cash on hand and future cash flow from operations.
The repurchase program permits LifeVantage to purchase shares
from time to time through a variety of methods, including in the
open market, through privately negotiated transactions or other
means as determined by the company's management, in accordance with
applicable securities laws. As part of the repurchase program, the
Company may enter into a pre-arranged stock repurchase plan which
will operate in accordance with guidelines specified under Rule
10b5-1 of the Securities Exchange Act of 1934. Accordingly,
transactions, if any, under the pre-arranged repurchase plan would
be completed in accordance with the terms of the stock repurchase
plan, including specified price, volume and timing
conditions. The authorization may be suspended or
discontinued at any time and expires on November 27, 2020.
About LifeVantage
Corporation
LifeVantage Corporation is a science-based health,
wellness and anti-aging company dedicated to helping people
transform themselves internally and externally at a cellular level.
Their scientifically-validated product lines include Protandim®
Nrf2 and NRF1 Synergizers, TrueScience® Anti-Aging Skin Care
Regimen, Petandim®, AXIO® Smart Energy and the PhysIQ™ Smart Weight
Management System. LifeVantage (Nasdaq:LFVN) was founded in 2003
and is headquartered in Salt Lake City, Utah. For more information,
visit www.lifevantage.com.
Forward Looking Statements
This document contains forward-looking statements made pursuant
to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Words and expressions reflecting optimism,
satisfaction or disappointment with current prospects, as well as
words such as "believe", "hopes", "intends", "estimates",
"expects", "projects", "plans", "anticipates", "look forward to",
"goal", "may be", and variations thereof, identify forward-looking
statements, but their absence does not mean that a statement is not
forward-looking. Examples of forward-looking statements include,
but are not limited to, statements we make regarding our
anticipated cash flow from operations and our expectation that we
will repurchase shares. Such forward-looking statements are
not guarantees of performance and the Company's actual results
could differ materially from those contained in such statements.
These forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the
Company and involve known and unknown risks and uncertainties that
may cause the Company's actual results or outcomes to be materially
different from those anticipated and discussed herein. These risks
and uncertainties include, among others, those discussed in greater
detail in the Company's Annual Report on Form 10-K and the
Company's Quarterly Report on Form 10-Q under the caption "Risk
Factors," and in other documents filed by the Company from time to
time with the Securities and Exchange Commission. The Company
cautions investors not to place undue reliance on the
forward-looking statements contained in this document. All
forward-looking statements are based on information currently
available to the Company on the date hereof, and the Company
undertakes no obligation to revise or update these forward-looking
statements to reflect events or circumstances after the date of
this document, except as required by law.
Investor Relations Contact:
Scott Van Winkle Managing Director, ICR (617)
956-6736scott.vanwinkle@icrinc.com
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Lifevantage (NASDAQ:LFVN)
Historical Stock Chart
From Apr 2023 to Apr 2024